These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 32582696)
1. Cathepsin S and Protease-Activated Receptor-2 Drive Alloimmunity and Immune Regulation in Kidney Allograft Rejection. Lei Y; Ehle B; Kumar SV; Müller S; Moll S; Malone AF; Humphreys BD; Andrassy J; Anders HJ Front Cell Dev Biol; 2020; 8():398. PubMed ID: 32582696 [TBL] [Abstract][Full Text] [Related]
2. The cathepsin-S/protease-activated receptor-(PAR)-2 axis drives chronic allograft vasculopathy and is a molecular target for therapeutic intervention. Ryll M; Lei Y; Thomas MN; Li M; Renz B; Wirth U; Kühn F; Bazhin A; Werner J; Anders HJ; Andrassy J Transpl Immunol; 2023 Apr; 77():101782. PubMed ID: 36608832 [TBL] [Abstract][Full Text] [Related]
3. Effective suppression of donor specific antibody production by Cathepsin S inhibitors in a mouse transplantation model. Kubo K; Kawato Y; Nakamura K; Nakajima Y; Nakagawa TY; Hanaoka K; Oshima S; Fukahori H; Inami M; Morokata T; Higashi Y Eur J Pharmacol; 2018 Nov; 838():145-152. PubMed ID: 30196110 [TBL] [Abstract][Full Text] [Related]
4. Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes Complications. Kumar Vr S; Darisipudi MN; Steiger S; Devarapu SK; Tato M; Kukarni OP; Mulay SR; Thomasova D; Popper B; Demleitner J; Zuchtriegel G; Reichel C; Cohen CD; Lindenmeyer MT; Liapis H; Moll S; Reid E; Stitt AW; Schott B; Gruner S; Haap W; Ebeling M; Hartmann G; Anders HJ J Am Soc Nephrol; 2016 Jun; 27(6):1635-49. PubMed ID: 26567242 [TBL] [Abstract][Full Text] [Related]
5. Pretreatment of donor islets with papain improves allograft survival without systemic immunosuppression in mice. Kumano K; Nishinakamura H; Mera T; Itoh T; Takahashi H; Fujiwara T; Kodama S Islets; 2016 Sep; 8(5):145-55. PubMed ID: 27618231 [TBL] [Abstract][Full Text] [Related]
6. Altered intragraft immune responses and improved renal function in MHC class II-deficient mouse kidney allografts. Mannon RB; Doyle C; Griffiths R; Bustos M; Platt JL; Coffman TM Transplantation; 2000 May; 69(10):2137-43. PubMed ID: 10852613 [TBL] [Abstract][Full Text] [Related]
8. CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II. Pietra BA; Wiseman A; Bolwerk A; Rizeq M; Gill RG J Clin Invest; 2000 Oct; 106(8):1003-10. PubMed ID: 11032860 [TBL] [Abstract][Full Text] [Related]
9. Pattern of graft- and host-specific MHC class II expression in long-term murine cardiac allografts: origin of inflammatory and vascular wall cells. Hasegawa S; Becker G; Nagano H; Libby P; Mitchell RN Am J Pathol; 1998 Jul; 153(1):69-79. PubMed ID: 9665467 [TBL] [Abstract][Full Text] [Related]
10. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling. Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138 [TBL] [Abstract][Full Text] [Related]
11. Targeted gene disruption of the heat shock protein 72 gene (hsp70.1) in the donor tissue is associated with a prolonged rejection-free survival in the murine skin allograft model. Oh KH; Kim JY; Kim D; Lee EM; Oh HY; Seo JS; Han JS; Kim S; Lee JS; Ahn C Transpl Immunol; 2004 Dec; 13(4):273-81. PubMed ID: 15589740 [TBL] [Abstract][Full Text] [Related]
12. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway. Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765 [TBL] [Abstract][Full Text] [Related]
13. The role of CD8 and CD4 T cells in intestinal allograft rejection: a comparison of monoclonal antibody-treated and knockout mice. He G; Hart J; Kim OS; Szot GL; Siegel CT; Thistlethwaite JR; Newell KA Transplantation; 1999 Jan; 67(1):131-7. PubMed ID: 9921809 [TBL] [Abstract][Full Text] [Related]
14. Unusual patterns of alloimmunity evoked by allogeneic liver parenchymal cells. Bumgardner GL; Orosz CG Immunol Rev; 2000 Apr; 174():260-79. PubMed ID: 10807522 [TBL] [Abstract][Full Text] [Related]
15. Allogeneic class I MHC requirement for alloantigen-reactive helper T-lymphocyte responses in vivo. Evidence for indirect presentation of alloantigen. Clement JD; Chan SY; Bishop DK Transplantation; 1996 Aug; 62(3):388-96. PubMed ID: 8779688 [TBL] [Abstract][Full Text] [Related]